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ABSTRACT
Objective To explore the natural course of hip 
osteoarthritis (OA) in a population of first- time 
presenters with hip complaints.
Methods Data were collected at baseline and after 2, 
5, 8 and 10 years on participants from the Cohort Hip 
and Cohort Knee study with early symptomatic hip OA. 
Descriptive statistics were used to analyse the natural 
course of the hip complaints with respect to clinical signs 
and symptoms, physical functioning and radiographic 
osteoarthritis (ROA) features.
Results In total, 588 participants were included 
with hip complaints and 86% completed the 10- year 
follow- up. The 10- year follow- up showed that 12% 
(69 participants) underwent hip replacement (HR), an 
increase of ROA of the hip (Kellgren and Lawrence 
score≥2) from 19% to 49%, and an increase in 
clinical hip OA according to the American College of 
Rheumatology criteria from 27% to 43%. All Western 
Ontario and McMaster Osteoarthritis Index subscales and 
physical activity remained on average constant during 
the 10- year follow- up for those who did not undergo an 
HR. The use of pain medication increased from 43% at 
baseline to 50% after 10 years.
Conclusion One out of nine participants with early hip 
problems received an HR during the 10- year follow- up. 
Prevalence of clinical hip OA and hip ROA increased 
steadily during the 10- year follow- up. Overall, we 
observed more hip OA, but fewer or stable complaints 
with respect to clinical signs and symptoms, and physical 
functioning. So it could be cautiously concluded that 
after 10 years, first- time presenters with hip complaints 
either received an HR or their symptoms remained stable.
INTRODUCTION
Osteoarthritis (OA) of the hip is a common problem 
in Western society and a common diagnosis in 
primary care.1 Hip OA affects 7%–25% of people 
older than 55 years.2 The number of affected hips 
will increase with further ageing of the popula-
tion.2 Pain in the hip and hip stiffness are the most 
common symptoms of hip OA.3 Consequently, 
patients are restricted in their activities, which 
has an impact on the health- related quality of life. 
For a disease so common and with an enormous 
impact on the affected patients, remarkably little 
is known about the natural course of early signs 
of hip OA. Most previous studies investigated the 
natural course of hip complaints combined with 
knee complaints.4 5 Knee OA is more common than 
hip OA and has been much more often studied.6 As 
a result, the natural course of hip complaints that 
may be indicating hip OA over time is still poorly 
characterised.
For many patients, the primary care physician 
(PCP) is the first physician they consult in their hip 
OA process. Therefore, it is important to investigate 
the natural course of hip complaints so that the PCP 
can start the most relevant non- surgical manage-
ment, and inform what to expect. The aim of the 
present study was to describe the natural course of 
hip complaints with respect to clinical signs and 
symptoms, physical functioning and radiographic 
osteoarthritis (ROA) features during the 10- year 




The data for this study were acquired from the 
Cohort Hip and Cohort Knee (CHECK) study; 
details on this cohort have been published else-
where.8 In short, the CHECK study is a prospec-
tive, 10- year follow- up cohort in the Netherlands 
of 1002 first presenters with hip and/or knee pain. 
Individuals entered the cohort between October 
2002 and September 2005. Inclusion criteria for 
the CHECK study were (1) stiffness and/or pain in 
the hip and/or knee, (2) age of 45–65 years, and (3) 
participants who had not yet consulted their PCP 
Key messages
What is already known about this subject?
 ► The natural course of hip complaints that may 
be indicating hip osteoarthritis (OA) over time is 
still poorly characterised.
What does this study add?
 ► This study provides long- term (10- year) follow- 
up data about the clinical signs and symptoms 
of hip OA in people with hip pain.
 ► One out of nine participants with early hip 
problems underwent a hip replacement during 
the follow- up.
 ► Prevalence of clinical hip OA and radiographic 
hip OA increased steadily during the 10- year 
follow- up, but complaints remained stable.
How might this impact on clinical practice or 
future developments?
 ► This study provides more information on long- 
term outcomes to determine the course of 
progression of hip OA.
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for these symptoms or (4) the participants’ first consultation was 
within 6 months of entry. Exclusion criteria were (1) other patho-
logical conditions that could explain the existing complaints (eg, 
other rheumatic disease, previous hip/knee joint replacement, 
congenital dysplasia, osteochondritis dissecans, intra- articular 
fractures, septic arthritis, Perthes' disease, ligament or meniscus 
damage, plica syndrome and Baker’s cyst); (2) comorbidity that 
would not allow physical evaluation during the follow- up; (3) 
malignancy in the past 5 years; and (4) inability to understand 
the Dutch language.
Study population
We included participants reporting hip pain at baseline. All 
participants were divided into subgroups twice; the first 
subgroups were a subgroup who reported hip pain (yes/no) only 
at baseline (H group) and a subgroup who reported hip and knee 
pain (yes/no) at baseline (H&K group). Subsequently, all partic-
ipants (regardless of whether they reported hip and knee pain at 
baseline) were divided into a second subgroup based on whether 
they underwent a hip replacement (HR) during follow- up (HR 
group) or did not receive an HR (no- HR group).
Outcome variables
Information about pain and other symptoms, physical func-
tioning, education level, height and weight (to calculate body 
Bass Index (BMI)), comorbidity, quality of life and psycho-
social factors was collected at five different points (at base-
line, after 2 years (T2), T5, T8 and T10). The information 
was collected by means of self- reported questionnaires and a 
physical examination. The Western Ontario and McMaster 
Osteoarthritis Index (WOMAC) was used to measure pain, 
stiffness and physical functioning (higher score indicating 
worse health). Pain intensity was assessed using the Numer-
ical Rating Scale (NRS) for pain intensity (range 0–10, higher 
scores indicating more pain). The participants were asked to 
score the pain intensity they experienced in their most painful 
joint over the past week and to score the present pain intensity 
in the same joint. At T5, T8 and T10, the participants were 
asked to report pain intensity related to the left and right hips 
for the past week. Of these measurements, we used the highest 
scores as the pain intensity outcome. In the physical exam-
ination, hip pain during flexion of the joint (yes/no) and pain 
during internal rotation of the hip (yes/no) were recorded. 
In addition, patients were asked whether they had morning 
Table 1 Baseline characteristics (mean (SD) or number (%)) of the study population and the subgroups
Baseline characteristics/factors
Total study 
population H group H&K group HR group No- HR group
Number of participants 588 170 418 69 518
Age (years), mean (SD) 55.8 (±5.3) 55.7 (±5.6) 55.8 (±5.2) 57.4 (±4.8) 55.6 (±5.3)
Female, n (%) 475 (81) 129 (76) 346 (83) 48(70) 426 (82)
Caucasian, n (%) 578 (99) 169 (99) 409 (98)† 68 (100) 509 (98)
Body Mass Index (kg/m2), mean (SD) 26.1 (±4.1)† 25.5 (±3.5)† 26.4 (±4.2)† 25.8 (±3.8)† 26.2 (±4.1)†
Education level, n (%)
 ►  Primary
 ►  Secondary





















Never smoked, n (%) 175 (30)† 56 (34)† 119 (29)† 29 (43)† 146 (29)†
No use of alcohol, n (%) 125 (22)† 30 (18)† 95 (23)† 17 (25)† 108 (22)†
Use of any pain medication, n (%) 250 (43)† 63 (38)† 187 (46)† 29 (43)† 221 (44)†
Three or more comorbidities, n (%) 152 (26)† 33 (20)† 119 (29)† 5 (7)† 147 (29)†
Baseline NRS (0–10) past week, mean (SD) 3.7 (±2.1)† 3.4 (±2.2)† 3.8 (±2.1)† 4.1 (±2.4)† 3.6 (±2.1)†
Baseline NRS (0–10) present pain, mean (SD) 3.2 (±2.1)† 2.8 (±2.0)† 3.4 (±2.1)† 3.8 (±2.4)† 3.2 (±2.0)†
Morning stiffness in the hip <60 min, n (%) 326 (55) 101 (59) 225 (54) 43 (62) 282 (54)
Knee pain, n (%) 418 (71) 0 (0) 418 (100) 31 (45) 386 (75)
Physically active (>30 min) for three or more times a week, n (%) 316 (55)† 103 (62)† 213 (53)† 34 (52)† 282 (56)†
WOMAC, mean (SD)
 ►  Pain (0–20)
 ►  Stiffness (0–8)
 ►  Physical function (0–68)





















Radiographic severity K/L grade ≥2 either hip, n (%) 110 (19)† 38 (23) † 72 (17)† 37 (54) 73 (14)†
Radiographic severity K/L grade ≥2 either knee, n (%) 76 (13)† 14 (8)† 62 (15)† 12 (17) 64 (13)†
Clinical hip OA,* either hip, n (%) 160 (27)† 51 (30)† 109 (26)† 34 (49) 125 (24)†
Clinical knee OA,* either knee, n (%) 206 (35)† 0 206 (50)† 12 (17) 194 (38)†
Physical examination, n (%)
 ► Painful internal rotation, either hip, n (%)











Values are mean value±SD or percentages (%).
Participants can be part of two subgroups, for example, H group and HR group.
*According to the clinical criteria of the American College of Rheumatology.
†≤4.3% missing.
H, subgroup who reported hip pain only at baseline ; H&K, subgroup who reported hip and knee pain at baseline; HR, group who underwent a hip replacement during follow- up; 
K/L, Kellgren and Lawrence; NRS, Numerical Rating Scale; WOMAC, Western Ontario and McMaster Osteoarthritis Index.
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stiffness in the hip (yes/no) and if they had hip and knee pain 
(yes/no).
At baseline, T2, T5, T8 and T10, standardised radiographs 
were collected of the anteroposterior view, pelvis view or unilat-
eral faux profile view of both hips and of the tibiofemoral joints 
(both knees). The radiographs were centrally scored for OA 
features9 according to the Kellgren and Lawrence (K/L) criteria10 
and for OA features according to criteria described by Altman and 
Gold.11 In the hip, all radiograph features showed good interob-
server reliability.9 Radiographic hip or knee OA was defined as 
K/L grade≥2.12 Information on HR and/or knee replacements 
was obtained from radiographs. Clinical hip and knee OA were 
determined according to the criteria of the American College of 
Rheumatology (ACR), which for the hip are hip pain and all of 
the following criteria under 1 or 2: (1) hip internal rotation of 
≥15°, pain present on internal rotation of the hip, morning stiff-
ness (≤60 min) and aged >50 years; (2) hip internal rotation of 
<15° and hip flexion of ≤115°.13 The ACR criteria for clinical 
knee OA are knee pain and ≥3 of the following symptoms: (1) 
aged >50 years, (2) morning stiffness (<30 min), (3) crepitus on 
active motion, (4) bony tenderness, (5) bony enlargement and 
(6) no palpable warmth of synovium.14 If a participant fulfilled 
these clinical ACR criteria at least once during follow- up, they 
were classed as a clinical hip/knee OA participant.
Statistical analysis
Descriptive statistics were used to analyse the baseline character-
istics and the course of the variables. The last observation carried 
forward (LOCF) from the last visit prior to HR was used for 
a subanalysis in the HR group to explore the course of symp-
toms if, as a thought experiment, HR had not been available (HR 
group with LOCF). Statistical analyses were performed using 
SPSS V.24.0 for Windows.
RESULTS
General characteristics
In total, 588 of the 1002 participants reported hip pain at base-
line. Of these 588 included participants, 170 participants (29%) 
reported only hip pain, 418 participants (71%) reported both hip 
and knee pain and 81 participants were lost to follow- up (online 
supplemental figure 1). Table 1 summarises the characteristics of 
the study population at baseline. At baseline, the mean age was 
55.8 (SD=5.2) years; the mean BMI was 26.1 (SD=4.1) kg/m2; 
and 81% was female. Most prominently, it shows that 19% of 
the participants had ROA of the hip, and 27% of the participants 
met the clinical ACR criteria for hip OA. More participants of 
the H group met the clinical hip OA criteria (30%) and showed 
ROA (23%) compared with participants of the H&K group at 
baseline (26% and 17%, respectively). During follow- up, 249 
participants (43%) fulfilled the criteria at ≥1 assessment. At 
baseline, 48 out of 160 participants (30%) with clinical hip OA 
also showed ROA in at least one hip.
Clinical and radiographic hip OA during follow-up
After 10 year, 131 out of 249 participants (53%) with clinical hip 
OA had ROA in at least one hip. Of the participants without clin-
ical hip OA at baseline, 62 out of 424 (15%) showed ROA in at 
least one hip at baseline and after 10 year 122 out of 267 (46%) 
did so. Most HRs (58 out of a total of 69) took place between T2 
and T8. Figure 1A shows the course of these outcomes, taking 
into account that a participant can only belong to one outcome 
group at each time point. During follow- up, clinical hip OA and 
ROA increased and more people received HRs (figure 1A).
Compared with participants of the H&K group, participants 
of the H group were as likely to meet the clinical hip OA criteria 
after follow- up (41% vs 43%) and were as likely to show ROA 
(48% vs 49%). After 10 years, participants of the H group were 
more likely to undergo an HR compared with participants of the 
H&K group (22% vs 7%). Figure 1B, C show the course of these 
outcomes, taking into account that a participant can only belong 
to one outcome group at each time point.
Clinical signs, symptoms and physical functioning during the 
10-year follow-up
Table 2 and online supplemental table 1 summarises the findings 
from 10 years follow- up. After 10 years, only 51% still reported 
hip pain and fewer participants reported morning stiffness in 
the hip (55% at baseline vs 45% after 10 years) than at baseline. 
Figure 1 Overview of percentages of participants (reported hip pain 
at baseline (A), reported only hip pain at baseline (B) and reported 
both hip and knee pain at baseline (C)) with hip replacement,clinical 
hip OA according to the ACR criteria and radiographic hip OA 
according to Kellgren and Lawrence score ≥2 over 10 years of follow- 
up. *cumulative. A: at t0 4 missing participants, at T2- T10 3 missing 
participants. B: at t0 1 missing participant. C: at t0 -T10 3 missing 
participants. OA, osteoarthritis.
copyright.











is: first published as 10.1136/annrheum




490 van Berkel AC, et al. Ann Rheum Dis 2021;80:487–493. doi:10.1136/annrheumdis-2020-218625
Osteoarthritis
In comparison with baseline, lower hip pain intensity over the 
past week was observed (3.7 (SD=2.1) vs 2.9 (SD=2.6)). Slight 
differences between baseline and the follow- up were observed in 
all WOMAC subscales. The use of any pain medication increased 
during follow- up (43% at baseline vs 50% after 10 years). The 
number of individuals who were physically active (>30 min≥3 
times/week) stayed stable over time (55% at baseline vs 56% 
after 10 years). During follow- up, the number of participants 
with clinical hip OA increased, as well as the participants with 
clinical knee OA (table 2). We observed a decrease in painful 
movements of the hip: painful internal rotation, external rotation 
and flexion of the hip are reported more frequently at baseline 
compared with the follow- up (table 2). Compared with partici-
pants of the H group, participants of the H&K group reported 
slightly higher scores for pain (intensity), stiffness and physical 
function during follow- up (online supplemental table 1).
Clinical signs, symptoms, physical functioning and HRs
Online supplemental table 2 summarises the findings for the 
10- year follow- up of the HR group and no- HR group. In addi-
tion (online supplemental table 2) shows the results for HR group 
with LOCF. Participants of the HR group have higher preva-
lence of ROA and were more likely to have met the clinical hip 
criteria at baseline. After 10 years, participants of the HR group 
reported lower pain intensity (both on the NRS, −1.9 points 
after 10 years) and on the WOMAC subscale (−2.6 points after 
10 years, in analysis without LOCF) and lower scores for physical 
function (−8.1 points on WOMAC physical function after 10 
years, in analysis without LOCF) compared with baseline. Use of 
any pain medication after 10 years seemed to decrease in persons 
of the HR group and increased in the no- HR group. Regarding 
the physical examination results, we observed an increase in 
painful movements of the hip in participants of the HR group: 
painful internal rotation, external rotation and flexion of the hip 
are reported more frequently after 10 years compared with the 
baseline (online supplemental table S2). However, at T10, only a 
small number of participants underwent a physical examination 
in the HR group. Figure 2 shows the course of (hip) pain inten-
sity over the past week, figure 3 the course of ROA and figure 4 
the course of clinical hip OA in the years preceding the HR (for 
the HR group). We observed higher pain intensity for the past 
week before HR compared with the pain intensity during the 
follow- up with an HR (figure 2). The percentage with ROA 
increased in the years before the HR; only a small proportion 
of participants had severe ROA (19%–35% K/L 3 and 0% K/L 4 
obtained from radiographs before HR) (figure 3). Most partici-
pants met the clinical hip OA criteria (69%–88%) before under-
going an HR (figure 4).
Table 2 Course of pain, physical functioning and radiographic OA features during follow- up, for total study group (n=588)
  Baseline T2 T5 T8 T10
WOMAC, mean (SD)
 ► Pain (0–20)
 ► Stiffness (0–8)
















NRS past week, mean (SD) 3.7 (±2.1) 3.7 (±2.3) 3.2 (±2.6) 2.7 (±2.5) 2.9 (±2.6)
Use any pain medication, n (%) 250 (43) 263 (48) 251 (47) 250 (49) 249 (50)
Hip pain, n (%) 588 (100) 374 (68) 301 (57) 267 (54) 247 (51)
Knee pain, n (%) 418 (71) 361 (65) 327 (62) 297 (58) 264 (53)
Morning stiffness (hip) <60 min, n (%) 326 (55) 287 (52) 272 (51) 239 (47) 228 (45)
Physically active (>30 min) for ≥3 times a week, n (%) 316 (55) 319 (60) 292 (56) 296 (58) 276 (56)
Cumulative sum of HR, n (%) 0 (0) 13 (2) 41 (7) 58 (10) 69 (12)
Cumulative sum of KR, n (%) 0 (0) 0 (0) 4 (1) 9 (2) 10 (2)
K/L grade ≥2 either hip, n (%) 110 (19) 128 (22) 151 (28) 183 (35) 253 (49)
Clinical knee OA* either knee, n (%) 206 (35) 278 (47) 323 (55) 349 (59) 366 (62)
Painful internal rotation either hip, n (%) 322 (55) 197 (36) 190 (38) 166 (36) 179 (39)
Painful external rotation either hip, n (%) 160 (35) 86 (17) 115 (20) 86 (15) 89 (20)
Painful flexion either hip, n (%) 315 (54) 227 (42) 192 (39) 149 (32) 159 (35)
Values are mean value±SD, or number (percentages, %).
*According to the clinical criteria of the ACR; once those clinical ACR criteria are satisfied, the case will be seen as clinical hip or knee OA.
ACR, American College of Rheumatology; HR, hip replacement; K/L, Kellgren and Lawrence; KR, knee replacement; NRS, Numerical Rating Scale; OA, osteoarthritis; WOMAC, 
Western Ontario and McMaster Osteoarthritis index.
Figure 2 Overview of self- reported NRS pain score in past week for participants who received an HR, represented per time point when they 
received an HR. Left of the red box (= when HR is seen on radiograph) pain scores before HR with intervals of 2 or 3 years,and right of the red box the 
pain scores with HR. The last row represents the weighted average pain scores for all participants.
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DISCUSSION
We observed that 12% of first- time presenters with hip complaints 
underwent an HR during 10 years follow- up. Furthermore, the 
prevalence of both clinical hip OA and ROA increased during 
follow- up. We observed less participants reporting hip pain, on 
average stable pain intensity, stable WOMAC pain scores and 
less reported pain during physical examination after 10 years 
compared with baseline, for those who did not undergo an HR. 
On the other hand, more participants were using any pain medi-
cation during follow- up. In general, the participants of the HR 
group had relatively higher pain intensity and higher prevalence 
of ROA and clinical hip OA before receiving the HR.
The WOMAC subscales and physical activity remained stable 
over time, which is in line with other longitudinal studies.15–17 
This may be based on regression to the mean, but it is also 
possible that at a group level, study participants truly do not 
get worse over time. Another explanation could be the response 
shift phenomenon,18 indicating that as time goes on, individuals 
learn to cope with their chronic disease. Many participants with 
mild OA have worse periods with more complaints followed by 
better periods with fewer complaints, and a response shift could 
have occurred in the self- reported questionnaires. Previous 
studies using trajectories showed that, on average, the majority 
remained stable, but they also showed that some of the subjects 
improved and stayed improved.19 20 A remarkable result is the 
decrease in the number of patients reporting hip pain (except 
for the HR group). This might be due to the fact that all partici-
pants started with pain at baseline, and therefore, the number of 
participant with hip pain could only stay stable (still have pain) 
or decrease at follow- up measurements. Furthermore, decreasing 
pain levels during physical examination over a period of 10 years 
is in line with previous studies21–23 and is a logical consequence 
of less hip pain.
We observed an increased use of any pain medication during 
follow- up. This increment could be an additional explanation 
for the stable WOMAC scores and an even decreasing trend in 
pain during physical examination. More experience in when to 
use pain medication and a positive response during flares might 
influence the overall pain intensity in patients with hip OA. This 
increase in the use of pain medication is in line with other litera-
ture. A study that investigated pain medication for knee OA also 
showed an increased use of paracetamol and non- steroidal anti- 
inflammatory drug over 3 years of follow- up.24 Other studies 
have shown that the use of (over- the- counter) pain medication 
among a general population has increased (modestly) over the 
past decades.25 26
In line with a previous study,27 we showed that patients with 
hip pain can have ROA without fulfilling the ACR criteria for 
clinical hip OA and vice versa. Our findings of the number of 
participants undergoing an HR are similar to those of other 
studies; a study with a 6- year follow- up reported rates for 
receiving an HR of 22%.28 This result is even higher than our 
findings, despite the shorter follow- up, but the mean age and 
the amount of ROA at baseline were higher in that particular 
study. Besides the increase in clinical hip OA, we also showed 
Figure 3 Overview of percentages of participants with radiographic hip OA according to Kellgren and Lawrence score ≥2 and noted in brackets the 
highest Kellgren and Lawrence score of any hip in time intervals of 2 or 3 years beforeHR. *=1 missing, **=2 missing.
Figure 4 Overview of percentages of participants with clinical hip OA 
in time intervals of 2 or 3 years before HR.
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an increase in clinical knee OA in patients with hip pain at base-
line. This might indicate that we have included some participants 
who initially had knee problems, as a recent study suggested that 
hip flexion and internal rotation might be affected by early knee 
OA.29 Thereby, we defined clinical hip (and knee) OA from the 
moment participants fulfilled the clinical ACR criteria; however, 
it is known that patients intermittently fulfilled the criteria over 
longer follow- up.20 It should also be mentioned that the ACR 
criteria are widely used in epidemiological research but are not 
validated in primary care.30
Twelve percent of the our study population underwent an HR 
during follow- up. It could be argued that an HR was justified for 
these participants because of the progression of their pain inten-
sity, and the majority had ROA and/or clinical hip OA preceding 
the HR. Nevertheless, they still did not have very high levels of 
pain intensity, and relatively only a small proportion of partic-
ipants with K/L≥2 had severe ROA. So it could still be consid-
ered as mild hip OA. The greatest benefit from joint replacement 
is expected if the procedure is restricted to patients with more 
severely affected functional status and more severe ROA.31 As 
shown in online supplemental table 2, it seems unlikely that 
participants of the HR group are suppressing the scores for the 
total group, because the outcomes for pain and physical function 
for our total group and the no- HR group are quite similar.
To our knowledge, this is the first study that provides long- 
term follow- up data about the clinical signs and symptoms of hip 
OA in people with hip pain. The strengths of the present study 
are that it is a population- based prospective longitudinal design, 
with a large sample of persons with early- stage symptomatic hip 
OA, monitored from the onset of disease management in primary 
care and a follow- up of 10 years. A limitation of the study is that, 
although participants were asked where the pain was located, 
participants were not asked to fill in the WOMAC questionnaire 
(at each follow- up moment) and NRS (at baseline and T2) for 
a specific joint. Therefore, we do not know if the NRS score, 
measured at baseline and at T2 for the participants who reported 
both hip and knee pain, was really pain due to hip symptoms. To 
solve this problem as well as we could, we selected participants 
with only hip pain at baseline as a subgroup, but still misclassi-
fication is possible. A second limitation to our study is that we 
had follow- up assessments every 2 or 3 years, at which we asked 
the participants about the pain intensity in the past week. So 
these results are not representative for the entire follow- up time. 
Future research with more frequent symptom assessment could 
solve this problem. Finally, pain could be reduced by other treat-
ments. We do not have information on the specific treatments 
people had.
This study provided more background information about the 
natural course of hip complaints during 10 years of follow- up in 
first presenters with hip complaints. In conclusion, we observed 
that the prevalence of clinical hip OA and ROA increased. After 
10 years of follow- up, one out of nine (11.7%) participants 
had undergone an HR. Overall, we observed more hip OA, but 
less participants reported hip pain. Complaints with respect to 
clinical signs and symptoms and physical functioning remained 
stable. It could be cautiously concluded that after 10 years, first- 
time presenters with hip complaints either underwent an HR, 
or their symptoms remained stable or improved slightly. Further 
research should aim to investigate how the course of pain inten-
sity in individuals changes over time and what factors are associ-
ated with the fluctuation of pain intensity.
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